Home > Quotes > NBIX > Competitors
NBIX

Neurocrine Biosciences, Inc. Competitors

$12.02
*  
0.01
  negative  
0.08%
Get NBIX Alerts
*Delayed - data as of May 21, 2013 15:03 ET 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    NBIX Real Time
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored

Competitor Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Neurocrine Biosciences, Inc.
CompanyName
Symbol: Market		 LastSale NetChange Volume Today's High/ Low 52 Weeks High/ Low P/ERatio Market Cap
Gilead Sciences, Inc.
GILD: NASDAQ-GS		 $ 56.67 0.93   6,391,395 $ 56.85
$ 55.76		 $ 57.10
$ 24.12		 31.75 86,274,011,310
Amgen Inc.
AMGN: NASDAQ-GS		 $ 104.40 2.22   2,474,053 $ 104.6399
$ 102.45		 $ 114.95
$ 67.61		 17.66 78,136,092,000
ARIAD Pharmaceuticals, Inc.
ARIA: NASDAQ-GS		 $ 17.21 0.59   1,727,453 $ 17.30
$ 16.68		 $ 25.40
$ 15.13		 NE 3,161,184,430
NPS Pharmaceuticals, Inc.
NPSP: NASDAQ-GM		 $ 14.58 0.47   1,614,455 $ 14.89
$ 13.79		 $ 14.77
$ 6.62		 NE 1,267,118,640
Life Technologies Corporation
LIFE: NASDAQ-GS		 $ 73.64 0.07   1,535,479 $ 73.69
$ 73.52		 $ 73.85
$ 39.73		 31.2 12,547,298,680
PDL BioPharma, Inc.
PDLI: NASDAQ-GS		 $ 8.302 0.09   1,459,159 $ 8.35
$ 8.22		 $ 8.43
$ 6.18		 5.39 1,161,723,766
Halozyme Therapeutics, Inc.
HALO: NASDAQ-GS		 $ 7.55 -0.02   1,170,673 $ 7.92
$ 7.42		 $ 9.92
$ 3.86		 NE 850,922,750
ONYX Pharmaceuticals, Inc.
ONXX: NASDAQ-GS		 $ 93.06 -1.28   1,017,191 $ 95.50
$ 92.71		 $ 101.569
$ 41.26		 NE 6,700,878,360
Biogen Idec Inc.
BIIB: NASDAQ-GS		 $ 232.62 7.44   912,265 $ 234.20
$ 226		 $ 234.46
$ 126.39		 36.92 54,970,897,440
Cel-Sci Corporation
CVM: AMEX		 $ .2599 0.01   766,324 $ .26
$ .25		 $ .5588
$ .205		 NE 80,369,917
Cardium Therapeutics, Inc.
CXM: AMEX		 $ .0925 0.00   709,542 $ .1017
$ .09		 $ .28
$ .0618		 NE 11,984,485
Hemispherx BioPharma, Inc.
HEB: AMEX		 $ .2079 0.00   683,182 $ .21
$ .1955		 $ 1.10
$ .18		 NE 34,767,117
Discovery Laboratories, Inc.
DSCO: NASDAQ-CM		 $ 1.65 -0.04   630,996 $ 1.73
$ 1.64		 $ 3.51
$ 1.50		 NE 71,804,700
Neuralstem, Inc.
CUR: AMEX		 $ 1.42 -0.03   619,285 $ 1.52
$ 1.38		 $ 1.96
$ .42		 NE 97,693,160
BioCryst Pharmaceuticals, Inc.
BCRX: NASDAQ-GS		 $ 1.71 unch 606,197 $ 1.71
$ 1.66		 $ 4.95
$ 1.08		 NE 87,004,800
Sangamo BioSciences, Inc.
SGMO: NASDAQ-GS		 $ 7.73 -0.13   506,671 $ 7.93
$ 7.62		 $ 11.24
$ 4.04		 NE 412,418,690
Novavax, Inc.
NVAX: NASDAQ-GS		 $ 1.985 0.01   481,479 $ 2.02
$ 1.97		 $ 2.77
$ 1.14		 NE 293,662,885
Qiagen N.V.
QGEN: NASDAQ-GS		 $ 18.581 0.07   435,222 $ 18.72
$ 18.53		 $ 22.20
$ 15.66		 37.16 4,394,164,947
Repros Therapeutics Inc.
RPRX: NASDAQ-CM		 $ 15.695 -0.04   423,105 $ 15.81
$ 15.14		 $ 20.78
$ 7.30		 NE 268,635,620
Neurocrine Biosciences, Inc.
NBIX: NASDAQ-GS		 $ 12.02 0.01   364,579 $ 12.12
$ 11.71		 $ 12.85
$ 6.25		 NE 799,438,180
Chelsea Therapeutics International, Ltd.
CHTP: NASDAQ-CM		 $ 1.885 0.05   352,960 $ 1.90
$ 1.82		 $ 2.17
$ .70		 NE 126,372,285
Curis, Inc.
CRIS: NASDAQ-GM		 $ 3.881 -0.03   333,020 $ 3.97
$ 3.78		 $ 5.51
$ 2.66		 NE 310,480,000
Vical Incorporated
VICL: NASDAQ-GS		 $ 3.65 0.04   325,571 $ 3.70
$ 3.60		 $ 4.74
$ 2.61		 NE 314,805,200
Seattle Genetics, Inc.
SGEN: NASDAQ-GS		 $ 35.66 -0.09   300,316 $ 36.20
$ 35.50		 $ 39
$ 19.03		 NE 4,294,819,080
Acorda Therapeutics, Inc.
ACOR: NASDAQ-GS		 $ 32.38 0.22   280,150 $ 32.46
$ 31.74		 $ 40.87
$ 21.26		 9.02 1,304,266,400